CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Switzerland

2 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Where

  Geneva

  Age

  18 years and over

  People

  218 worldwide

  Run by

  argenx

  See details and how to joinNCT06920004 · EU 2024-520097-36-00
• Phase 3Taking people
  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Basel, Bern

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06290141 · EU 2023-508338-33-00